The glycemic gap as a prognostic indicator in cardiogenic shock: a retrospective cohort study

Qianqian Xu1, Jinsheng Wang1, Zhihui Lin1

  • 1Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Xueyuanxi Road, No 109, Wenzhou , Zhejiang, 325027, China.

PubMed

Insights

The glycemic gap (GG) indicates stress-induced hyperglycemia and predicts poor outcomes in cardiogenic shock (CS) patients, irrespective of diabetes. Higher GG levels correlate with increased 30-day mortality and lactic acid levels in CS.

Area of Science:

  • Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Stress-induced hyperglycemia (SIH) is linked to adverse outcomes in cardiogenic shock (CS).
  • The glycemic gap (GG), calculated as blood glucose minus A1c-derived average glucose, is a key indicator of SIH.
  • Previous studies show inconsistent results regarding SIH and outcomes in CS patients with or without diabetes mellitus (DM).

Purpose of the Study:

  • To investigate the prognostic role of the glycemic gap (GG) in patients with cardiogenic shock (CS).
  • To explore the association between GG and 30-day mortality in CS patients.
  • To examine the correlation between GG and lactic acid levels in CS.

Main Methods:

  • Utilized data from the MIMIC-IV v2.0 database for CS patients to assess GG and 30-day mortality.
  • Included CS patients from the Second Affiliated Hospital of Wenzhou Medical University to analyze GG and lactic acid correlation.
  • Applied multivariate analysis, propensity score-matched (PSM) analysis, and inverse probability treatment weighting (IPTW).

Main Results:

  • Both absolute and relative glycemic gaps (GG) were significantly associated with increased 30-day all-cause mortality in CS patients.
  • Higher GG levels correlated with elevated lactic acid, indicating increased severity.
  • GG improved the predictive value of the Glasgow Coma Scale (GCS) for mortality, irrespective of diabetes status.

Conclusions:

  • The glycemic gap (GG) is a valuable predictor of 30-day mortality in cardiogenic shock (CS) patients, independent of diabetes mellitus (DM).
  • GG reflects CS severity and is linked to hyperlactatemia and insulin resistance.
  • GG enhances the prognostic capability of existing clinical scores like the GCS.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68